Financhill
Back

Addex Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
21

ADXN
Addex Therapeutics

Last Price:
8.30
Seasonality Move:
34.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Addex Therapeutics Price Quote

$8.30
-0.33 (-3.82%)
(Updated: November 14, 2024 at 12:10 PM ET)

Addex Therapeutics Key Stats

Sell
21
Addex Therapeutics (ADXN) is a Sell

Day range:
$8.59 - $9.89
52-week range:
$5.00 - $27.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.22
P/B ratio:
0.66%

Volume:
128.6K
Avg. volume:
41.3K
1-year change:
59.52%
Market cap:
$9.2M
Revenue:
$1.8M
EPS:
$-1.64

How Much Does Addex Therapeutics Make?

Is Addex Therapeutics Growing As A Company?

  • What Is Addex Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.82%
  • What Is Addex Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Addex Therapeutics Stock Price Performance

What Is Addex Therapeutics 52-Week High & Low?

Addex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Addex Therapeutics?

Is Addex Therapeutics Cash Flow Positive?

  • What Is ADXN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.7M
  • What Is Addex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$151K
  • What Is Addex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.2M

Addex Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADXN return on invested capital is 90.28%
  • What Is Addex Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 54.9%
  • What Is ADXN Return On Equity?
    ROE is a measure of profitability and is 90.28%

Addex Therapeutics Earnings Date & Stock Price

Addex Therapeutics Competitors

Addex Therapeutics Dividend Yield

Addex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -81.84% -47.81%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 247.62%

Major Shareholders

  • How many ADXN shares are owned by institutional investors?
    4.6M ADXN shares are owned by institutional investors
  • How many ADXN shares are owned by insiders?
    0 ADXN shares are owned by insiders